Tchaikapharma High Quality Medicines AD
THQM | BSOBGN
Overview
Corporate Details
- ISIN(s):
- BG1100008074
- LEI:
- 5299003VDHTK75D1JE38
- Country:
- Bulgaria
- Address:
- бул./ул. бул. Г.М.ДИМИТРОВ № 1, 1172 София
- Website:
- https://tchaikapharma.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Tchaikapharma High Quality Medicines Inc. is the fastest growing pharmaceutical manufacturer operating in Bulgaria. The company is focused on making available contemporary therapeutical solutions on the local, regional and European market in accordance with Good Manufacturing Practice (GMP). Our expertise in fast market penetration is proven by the results we have achieved and continue to achieve for our partners. Our success is built on true respect for the patient and a lasting bond with physicians. Pursuant to its core strategic objectives of transparency and growth, Tchaikapharma goes public in 2015. The company’s shares have been traded successfully on the Bulgarian Stock Exchange since then.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-04-15 23:00 |
Annual Audited Financial Statements
5299003VDHTK75D1JE38-20231231-BG-CON_CALCULATION-RES.html
|
English | 47.8 KB | |
| 2024-04-15 23:00 |
Regulatory News Service
609557-7TH_2023 CONS_BG_signed.xls
|
Bulgarian | 719.5 KB | |
| 2024-04-15 23:00 |
Regulatory News Service
609559-7TH_2023 CONS_EN_signed.xls
|
Bulgarian | 235.0 KB | |
| 2024-04-15 23:00 |
Regulatory News Service
609558-5299003VDHTK75D1JE38-20231231-EN-CON.zip
|
Bulgarian | 6.4 MB | |
| 2024-03-26 23:00 |
Regulatory News Service
608037-SPRAVKA_1_IND_GFO_6M.xls
|
Bulgarian | 722.0 KB | |
| 2024-03-26 23:00 |
Regulatory News Service
5299003VDHTK75D1JE38-20231231-BG-SEP.xhtml
|
Bulgarian | 21.8 MB | |
| 2023-07-12 23:00 |
Regulatory News Service
7TH_2022 CONS_BG.xls
|
Bulgarian | 718.0 KB | |
| 2023-06-07 23:00 |
Regulatory News Service
SPRAVKA_1_IND_GFO_6M_signed.xls
|
Bulgarian | 778.5 KB | |
| 2023-06-07 23:00 |
Regulatory News Service
5299003VDHTK75D1JE38-20221231-BG-SEP.xhtml
|
Bulgarian | 37.0 MB | |
| 2022-07-26 23:00 |
Regulatory News Service
5299003VDHTK75D1JE38-20211231-BG-SEP.xhtml
|
Bulgarian | 5.7 MB | |
| 2022-07-26 23:00 |
Regulatory News Service
7TH_2021_signed.xls
|
Bulgarian | 939.0 KB | |
| 2022-07-26 23:00 |
Regulatory News Service
5299003VDHTK75D1JE38-20211231-BG-CON.zip
|
Bulgarian | 3.2 MB | |
| 2022-07-26 23:00 |
Regulatory News Service
7TH_2021 CONS.xls
|
Bulgarian | 900.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
KANABO GROUP PLC | United Kingdom | KNB | |
|
Karo Pharma AB | Sweden | KARO | |
|
Kinarus Therapeutics Holding AG | Switzerland | KNRS | |
|
Klaria Pharma Holding AB | Sweden | KLAR | |
|
Kolinpharma | Italy | KIP | |
|
Krka | Slovenia | KRKG | |
|
Kyivmedpreparat | Ukraine | KMED | |
|
Labiana S.A. | Spain | LAB | |
|
Labocanna Spolka Akcyjna | Poland | LCN | |
|
Laboratorio Farmaceutico Erfo | Italy | ERFO |